News & Events

WEBINAR ON ALK TESTING AND NSCLC NOW AVAILABLE

by Insight Genetics
July 16, 2015

QIAGEN hosted a webinar with presentations by Insight Genetics Chief Scientific Officer Dr. Stephan Morris and Dr. David Saltman, medical oncologist at the British Columbia Cancer Agency, on developments and challenges in anaplastic lymphoma kinase (ALK) testing for the advancement of precision medicine for non-small cell lung cancer (NSCLC) patients.

Page 3 of 15 (73 items)

|< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 >|